Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1992 Oct;66(4):739–743. doi: 10.1038/bjc.1992.349

Proliferating cell nuclear antigen (PCNA) as a prognostic factor in non-Hodgkin's lymphoma.

P J Klemi 1, K Alanen 1, S Jalkanen 1, H Joensuu 1
PMCID: PMC1977428  PMID: 1358164

Abstract

The prognostic value of immunoperoxidase staining for proliferating cell nuclear antigen (PCNA) was studied in a series of 140 non-Hodgkin's lymphomas with median follow-up of 9 years. Lymphomas where > 50% of cells showed positive staining for PCNA had inferior 5-year survival as compared with those with less than 50% of positive cells (57% vs 41%, P = 0.008). The presence of > 50% of positively staining cells for PCNA was strongly associated with a larger than the median size of the SPF (median, 8.3%), and high histological grade of malignancy (P < 0.0001 for both). Lymphomas with both a large percentage (> 50%) of PCNA positive cells and a larger than the median SPF had inferior outcome as compared with lymphomas where either one or both of these factors were small. Although PCNA staining was not an independent prognostic factor in a multivariate analysis, it appears to be supplementary to the SPF even if determined from old paraffin-embedded tissue material.

Full text

PDF
739

Images in this article

740Figure 1
on p.740

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bravo R., Celis J. E. A search for differential polypeptide synthesis throughout the cell cycle of HeLa cells. J Cell Biol. 1980 Mar;84(3):795–802. doi: 10.1083/jcb.84.3.795. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bravo R., Frank R., Blundell P. A., Macdonald-Bravo H. Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta. Nature. 1987 Apr 2;326(6112):515–517. doi: 10.1038/326515a0. [DOI] [PubMed] [Google Scholar]
  3. Brown D. C., Gatter K. C., Mason D. Y. Proliferation in non-Hodgkin's lymphoma: a comparison of Ki-67 staining on fine needle aspiration and cryostat sections. J Clin Pathol. 1990 Apr;43(4):325–328. doi: 10.1136/jcp.43.4.325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Camplejohn R. S., Macartney J. C., Morris R. W. Measurement of S-phase fractions in lymphoid tissue comparing fresh versus paraffin-embedded tissue and 4',6'-diamidino-2 phenylindole dihydrochloride versus propidium iodide staining. Cytometry. 1989 Jul;10(4):410–416. doi: 10.1002/cyto.990100408. [DOI] [PubMed] [Google Scholar]
  5. Christensson B., Lindemalm C., Johansson B., Mellstedt H., Tribukait B., Biberfeld P. Flow cytometric DNA analysis: a prognostic tool in non-Hodgkin's lymphoma. Leuk Res. 1989;13(4):307–314. doi: 10.1016/0145-2126(89)90067-2. [DOI] [PubMed] [Google Scholar]
  6. Christensson B., Tribukait B., Linder I. L., Ullman B., Biberfeld P. Cell proliferation and DNA content in non-Hodgkin's lymphoma. Flow cytometry in relation to lymphoma classification. Cancer. 1986 Sep 15;58(6):1295–1304. doi: 10.1002/1097-0142(19860915)58:6<1295::aid-cncr2820580620>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  7. Cowan R. A., Harris M., Jones M., Crowther D. DNA content in high and intermediate grade non-Hodgkin's lymphoma-prognostic significance and clinicopathological correlations. Br J Cancer. 1989 Dec;60(6):904–910. doi: 10.1038/bjc.1989.388. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gerdes J., Dallenbach F., Lennert K., Lemke H., Stein H. Growth fractions in malignant non-Hodgkin's lymphomas (NHL) as determined in situ with the monoclonal antibody Ki-67. Hematol Oncol. 1984 Oct-Dec;2(4):365–371. doi: 10.1002/hon.2900020406. [DOI] [PubMed] [Google Scholar]
  9. Grogan T. M., Lippman S. M., Spier C. M., Slymen D. J., Rybski J. A., Rangel C. S., Richter L. C., Miller T. P. Independent prognostic significance of a nuclear proliferation antigen in diffuse large cell lymphomas as determined by the monoclonal antibody Ki-67. Blood. 1988 Apr;71(4):1157–1160. [PubMed] [Google Scholar]
  10. Hall P. A., Levison D. A., Woods A. L., Yu C. C., Kellock D. B., Watkins J. A., Barnes D. M., Gillett C. E., Camplejohn R., Dover R. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol. 1990 Dec;162(4):285–294. doi: 10.1002/path.1711620403. [DOI] [PubMed] [Google Scholar]
  11. Jain S., Filipe M. I., Hall P. A., Waseem N., Lane D. P., Levison D. A. Prognostic value of proliferating cell nuclear antigen in gastric carcinoma. J Clin Pathol. 1991 Aug;44(8):655–659. doi: 10.1136/jcp.44.8.655. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Joensuu H., Klemi P. J., Söderström K. O., Jalkanen S. Comparison of S-phase fraction, working formulation, and Kiel classification in non-Hodgkin's lymphoma. Cancer. 1991 Oct 1;68(7):1564–1571. doi: 10.1002/1097-0142(19911001)68:7<1564::aid-cncr2820680718>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  13. Kamel O. W., LeBrun D. P., Davis R. E., Berry G. J., Warnke R. A. Growth fraction estimation of malignant lymphomas in formalin-fixed paraffin-embedded tissue using anti-PCNA/Cyclin 19A2. Correlation with Ki-67 labeling. Am J Pathol. 1991 Jun;138(6):1471–1477. [PMC free article] [PubMed] [Google Scholar]
  14. Lenner P., Roos G., Johansson H., Lindh J., Dige U. Non-Hodgkin lymphoma. Multivariate analysis of prognostic factors including fraction of S-phase cells. Acta Oncol. 1987;26(3):179–183. doi: 10.3109/02841868709091427. [DOI] [PubMed] [Google Scholar]
  15. Miyachi K., Fritzler M. J., Tan E. M. Autoantibody to a nuclear antigen in proliferating cells. J Immunol. 1978 Dec;121(6):2228–2234. [PubMed] [Google Scholar]
  16. Witzig T. E., Gonchoroff N. J., Greipp P. R., Katzmann J. A., Stenson M. J., Habermann T. M., Colgan J. P., Therneau T. M., Banks P. M. Rapid S-phase determination of non-Hodgkin's lymphomas with the use of an immunofluorescence bromodeoxyuridine labeling index procedure. Am J Clin Pathol. 1989 Mar;91(3):298–301. doi: 10.1093/ajcp/91.3.298. [DOI] [PubMed] [Google Scholar]
  17. Woods A. L., Hall P. A., Shepherd N. A., Hanby A. M., Waseem N. H., Lane D. P., Levison D. A. The assessment of proliferating cell nuclear antigen (PCNA) immunostaining in primary gastrointestinal lymphomas and its relationship to histological grade, S+G2+M phase fraction (flow cytometric analysis) and prognosis. Histopathology. 1991 Jul;19(1):21–27. doi: 10.1111/j.1365-2559.1991.tb00890.x. [DOI] [PubMed] [Google Scholar]
  18. Young G. A., Hedley D. W., Rugg C. A., Iland H. J. The prognostic significance of proliferative activity in poor histology non-Hodgkin's lymphoma: a flow cytometry study using archival material. Eur J Cancer Clin Oncol. 1987 Oct;23(10):1497–1504. doi: 10.1016/0277-5379(87)90092-7. [DOI] [PubMed] [Google Scholar]
  19. Yu C. C., Hall P. A., Fletcher C. D., Camplejohn R. S., Waseem N. H., Lane D. P., Levison D. A. Haemangiopericytomas: the prognostic value of immunohistochemical staining with a monoclonal antibody to proliferating cell nuclear antigen (PCNA). Histopathology. 1991 Jul;19(1):29–33. doi: 10.1111/j.1365-2559.1991.tb00891.x. [DOI] [PubMed] [Google Scholar]
  20. van Dierendonck J. H., Wijsman J. H., Keijzer R., van de Velde C. J., Cornelisse C. J. Cell-cycle-related staining patterns of anti-proliferating cell nuclear antigen monoclonal antibodies. Comparison with BrdUrd labeling and Ki-67 staining. Am J Pathol. 1991 May;138(5):1165–1172. [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES